Title:
PEPTIDE AND ITS DERIVATIVES CAPABLE OF INHIBITING REPLICATION OF HEPATITIS C VIRUS IN HUMAN ADIPOSE-DERIVED STEM CELLS AND HEPATOCYTES
Document Type and Number:
WIPO Patent Application WO/2016/165101
Kind Code:
A1
Abstract:
The present invention provides a peptide with sequence of DEAQETAVSSHEQD, a fragment of rabbit-α1 antiproteinase F, and its derivatives DEAQETAVSSHEQ and QETACSSHEQD, which significantly inhibit serum-borne HCV replication in hADSC and human hepatocytes.
Inventors:
LIN CHEN-LUNG (TW)
Application Number:
PCT/CN2015/076744
Publication Date:
October 20, 2016
Filing Date:
April 16, 2015
Export Citation:
Assignee:
INNO BIO-DRUG DEV LTD (GB)
LIN CHEN-LUNG (CN)
LIN CHEN-LUNG (CN)
International Classes:
C07K7/08; A61K38/08; A61K38/10; A61P23/00; A61P25/00; A61P31/16
Domestic Patent References:
| WO2007097492A1 | 2007-08-30 |
Foreign References:
| CN104321337A | 2015-01-28 | |||
| US20120135931A1 | 2012-05-31 |
Other References:
See also references of EP 3283503A4
Attorney, Agent or Firm:
CHINA PATENT AGENT (H.K.) LTD. (CN)
Download PDF:
Previous Patent: RECTIFICATION CIRCUIT
Next Patent: THERAPEUTIC PEPTIDES FOR CEREBROVASCULAR DISEASES
Next Patent: THERAPEUTIC PEPTIDES FOR CEREBROVASCULAR DISEASES